Lanthanum Carbonate (Fosrenol, BAY77-1931) - chewable tablet

DRUG2 trials

Sponsors

Bayer

Conditions

Hyperphosphatemia

Unknown Phase

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan

CompletedNCT01412398

BayerHyperphosphatemia

Start: 2009-04-07End: 2016-09-01Updated: 2018-01-19

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan

CompletedNCT01419327

BayerHyperphosphatemia

Start: 2009-03-23End: 2019-05-28Updated: 2020-05-20